IT0005274094
IT0005274094
PHARMANUTRA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 680.8M EUR | 839.74M EUR | 753.57M EUR | 519.93M EUR |
Enterprise Value | 684.02M EUR | 850.88M EUR | 751.5M EUR | 521.87M EUR |
Valuation Multiples | ||||
Trailing P/E | 33.22x | 40.48x | 35.85x | 29.6x |
Forward P/E | 22.75x | -- | -- | -- |
Price to Sales | 4.74x | 5.83x | 5.4x | 4.9x |
Price to Book | 9.79x | 12.05x | 10.1x | 7.29x |
EV/Revenue | 4.76x | 5.91x | 5.38x | 4.91x |
EV/EBITDA | 20.6x | 24.25x | 21.14x | 17.92x |
Price to FCF (P/FCF) | 43.5x | 55.9x | 47.06x | 34.55x |
EV/FCF | 43.71x | 56.64x | 46.93x | 34.68x |
FCF Yield | 2.3% | 1.79% | 2.12% | 2.89% |